William Jeffrey Petty, MD
- Professor, Hematology and Oncology

William Jeffrey Petty, MD
- Education
- BA, Harvey Mudd College, 1994
- MD, University of North Carolina at Chapel Hill School of Medicine, 1998
- Residency
- Internal Medicine, Duke University Hospital, 2001
- Fellowship
- Medical Oncology, Mary Hitchcock Memorial Hospital, 2004
- Board Certifications
- American Board of Internal Medicine, Medical Oncology
- Memberships
- American Society of Clinical Oncology
- American Association of Cancer Research
- American College of Chest Physicians
- Positions
- Professor, Hematology and Oncology
- Associate Professor, Cancer Biology
- Departments and Affiliations
- Hematology and Oncology
- Cancer Biology
- Comprehensive Cancer Center
Research
- Lung Cancer Patient and Caregiver Health Vulnerabilities and Interest in Health Promotion Interventions: An Exploratory Study. Nightingale CL, Steffen LE, Tooze JA, Petty W, Danhauer SC, Badr H, Weaver KE. . 2019; 8:2164956119865160.
- Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis. Bonomi M, Ahmed T, Addo S, Kooshki M, Palmieri D, Levine BJ, Ruiz J, Grant S, Petty WJ, Triozzi PL. . 2019 Jan; 17(1):1349-1356.
- Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature. Lewis JA, Petty WJ, Urbanic J, Bernstein ED, Ahmed T. . 2018 Nov; 10(11):e3586.
- Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. Ruiz J, Miller AA, Tooze JA, Crane S, Petty WJ, Gajra A, Klepin HD. J Geriatr Oncol. 2019 01; 10(1):48-54.
- Severe neurologic complications of immune checkpoint inhibitors: a single-center review. Mancone S, Lycan T, Ahmed T, Topaloglu U, Dothard A, Petty WJ, Strowd RE. J. Neurol. 2018 Jul; 265(7):1636-1642.